Published date: 13 January 2022

Last edited date: 24 February 2022

Closed early engagement


Closing date: 24 February 2022

Contract summary

Industry

  • Hospital and related services - 85110000

Location of contract

England

Procurement reference

NHSX DCHM 001_22

Published date

13 January 2022

Closing date

24 February 2022

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Yes

Description

Thank you for your interest in IDecide. We were hoping to meet some of you in our supplier workshop on 3 March. However, due to circumstances beyond our control we have had to reschedule this meeting to a later date.

We hope the webinar will take place in Mid May and a new call for expressions of interest will be published as soon as possible. Any supplier who has already registered their interest will be contacted directly with the new date.
Thank you for your patience and we look forward to working with you in the future.

Background

The iDecide team, comprised of NHSE&I and NHSX colleagues, commenced a collaborative Discovery and Alphas phase in March 2020. The aims initially were to test the validity of both the iDecide acronym structure and a digital tool being used to stimulate the discussion of informed decision-making and consent. This was followed by an Alpha phase developing the digital iDecide tool and Feasibility testing to ensure clinician input at local level.

IDecide stands for

Immediacy (how urgent is the situation?)
Details of the situation (what's happening?)
Exchange of information (including the PCSP)
Choices (options available and access to information, including BRAIN)
I confirm I understand (opportunity to ask questions)
Decision (and consent)
Evaluation* (during the postnatal period)

In 2020/21 a digital prototype of 'iDecide' was developed and the concept has been feasibility tested in 3 maternity units. Development of the digital tool and wider piloting is now required to further evaluate the initial findings.

Where 'iDecide' has been feasibility tested, testing suggests:

1)Staff are better equipped for intrapartum conversations, so delay in time sensitive interventions by protracted discussion at that point is avoided, therefore preventing brain injury/neonatal mortality/morbidity

2)Those giving birth are more prepared, and have improved experience, having received information and had personalised conversations antenatally, so that informed-decision making and consent is facilitated

Next Steps
Following the feasibility study, there is now a need to ensure that any future solution can meet the needs of the service

Next steps would be to develop a specification that we can take to market and establish if there is a new appetite to offer solutions. Before we engage in a formal procurement. Therefore we would like to seek expressions of interest from the market and whether organisations would be happy to attend a webinar of 3rd March 2022 (details to follow)

To express an interest in potentially engaging in future dialogue for this programme and to receive an invite to the webinar please contact us via email at england.digitalmaternitynhsx@nhs.net with the following information

Organisation Name

Contact person
Contact details Phone & Email.
1-2 sentences on what your organisation delivers.

More information

Attachments

About the buyer

Contact name

Ben Farrelly

Address

Skipton House,
80 London Road
LONDON
SE1 6LH
England

Telephone

07919560636

Email

england.digitalmaternitynhsx@nhs.net